We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
Cap. Flow
-$936M
Cap. Flow %
-9.97%
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$109M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$60M
3
QCOM icon
Qualcomm
QCOM
+$51.7M
4
TXN icon
Texas Instruments
TXN
+$40M
5
MSFT icon
Microsoft
MSFT
+$37.6M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.72B
2
INTC icon
Intel
INTC
+$70.3M
3
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$60.1M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$43.5M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$21.8M

Sector Composition

Rank Sector Weight
1 Technology 37.79%
2 Financials 14.33%
3 Healthcare 10.38%
4 Energy 7.34%
5 Consumer Discretionary 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
376
Kymera Therapeutics
KYMR
$8.51B
$3.91M 0.04%
179,642
+29,303
+19% +$772K
ARCT icon
377
Arcturus Therapeutics
ARCT
$164M
$3.87M 0.04%
260,980
+60,794
+30% +$1.02M
KURA icon
378
Kura Oncology
KURA
$800M
$3.85M 0.04%
281,914
+186,640
+196% +$2.88M
AGIO icon
379
Agios Pharmaceuticals
AGIO
$1.79B
$3.85M 0.04%
135,992
+16,734
+14% +$449K
ALT icon
380
Altimmune
ALT
$552M
$3.83M 0.04%
+300,331
New +$4.43M
CCI icon
381
Crown Castle
CCI
$33.3B
$3.75M 0.04%
25,943
+5,360
+26% +$917K
DCPH
382
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.74M 0.04%
202,053
+45,467
+29% +$714K
SYK icon
383
Stryker
SYK
$125B
$3.65M 0.04%
18,015
+9,849
+121% +$2.07M
KPTI icon
384
Karyopharm Therapeutics
KPTI
$43.5M
$3.65M 0.04%
44,534
+13,907
+45% +$1.04M
KRYS icon
385
Krystal Biotech
KRYS
$10.1B
$3.64M 0.04%
52,256
+19,064
+57% +$1.38M
PM icon
386
Philip Morris
PM
$297B
$3.62M 0.04%
+43,557
New +$4.15M
RCKT icon
387
Rocket Pharmaceuticals
RCKT
$340M
$3.62M 0.04%
226,518
+139,896
+162% +$2.18M
NKE icon
388
Nike
NKE
$61.9B
$3.59M 0.04%
43,206
+37,752
+692% +$4.06M
EG icon
389
Everest Group
EG
$14.5B
$3.56M 0.04%
13,548
+1,189
+10% +$322K
SNDX icon
390
Syndax Pharmaceuticals
SNDX
$1.69B
$3.52M 0.04%
146,382
+68,478
+88% +$1.54M
ASHR icon
391
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
$3.47M 0.04%
+128,165
New +$3.93M
PMVP icon
392
PMV Pharmaceuticals
PMVP
$59.2M
$3.44M 0.04%
289,318
+49,454
+21% +$714K
OCGN icon
393
Ocugen
OCGN
$416M
$3.44M 0.04%
1,933,907
+548,173
+40% +$1.36M
L icon
394
Loews
L
$23.9B
$3.42M 0.04%
68,707
+4,035
+6% +$226K
BDX icon
395
Becton Dickinson
BDX
$45.6B
$3.4M 0.04%
15,243
+8,327
+120% +$2.07M
LFG
396
DELISTED
Archaea Energy Inc.
LFG
$3.38M 0.04%
187,970
-105,812
-36% -$1.86M
IT icon
397
Gartner
IT
$10.1B
$3.38M 0.04%
12,217
+1,418
+13% +$398K
CDMO
398
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3.33M 0.04%
174,295
+52,226
+43% +$952K
EPAM icon
399
EPAM Systems
EPAM
$5.51B
$3.33M 0.04%
9,191
+665
+8% +$254K
ARQT icon
400
Arcutis Biotherapeutics
ARQT
$3.36B
$3.33M 0.04%
173,983
+131,606
+311% +$2.98M
14 15
16
17 18

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.

  • Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
  • Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
  • Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
  • Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
  • Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
  • Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.